Member Posts > Cardiol Therapeutics: The Next Step in Treating Heart Failure with Cannabidiol
Pioneering a New Approach to Heart Failure
CRD-38 is an investigational cannabidiol therapy designed to address chronic inflammation and cardiac remodeling, two key drivers of heart failure progression.
Why CRD-38 is Different
✔ Increases drug bioavailability, ensuring higher therapeutic efficacy.
✔ Provides sustained plasma levels, reducing fluctuations in drug activity.
✔ Less frequent dosing, improving patient convenience and adherence.
Scientific Backing for CRD-38
📌 BNP biomarker reduction, signaling improved cardiac function.
📌 Lower fat accumulation, reducing strain on the heart.
📌 Confirmed anti-inflammatory effects, reinforcing its cardioprotective benefits.
Clinical Development Updates
CRD-38 is currently in IND-enabling studies, with:
✔ Pharmacokinetic research ongoing.
✔ Safety testing in progress.
✔ First-in-human trials planned.
🔗 Discover More About CRD-38's Clinical Pathway:

#HeartHealth #CardiolTherapeutics #MedicalBreakthrough #CRD38 #CardiacCare